| Drug Name | Levoflox (levofloxacin), Omacip (ciprofloxacin) |
|---|---|
| Drug Class |
Antibiotic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
Systemic and inhaled fluoroquinolones Levoflox (Levofloxacin) and Omacip (Ciprofloxacin): Warning about new risk of heart valve regurgitation/incompetence |
| Dear Healthcare provider letter DHPC |
|